834 related articles for article (PubMed ID: 10730528)
21. [Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus].
Anić B; Crkvencić N; Mayer M; Bosnić D; Sentić M; Markeljević J; Cikes N
Lijec Vjesn; 1999; 121(9-10):283-8. PubMed ID: 19658369
[TBL] [Abstract][Full Text] [Related]
22. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy.
Barbano G; Gusmano R; Damasio B; Alpigiani MG; Buoncompagni A; Gattorno M; Perfumo F
J Nephrol; 2002; 15(2):123-9. PubMed ID: 12018627
[TBL] [Abstract][Full Text] [Related]
23. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
[TBL] [Abstract][Full Text] [Related]
24. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
25. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
Morović-Vergles J; Galesić K; Dancuo I; Vergles D
Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
[TBL] [Abstract][Full Text] [Related]
26. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up.
Moroni G; Gallelli B; Quaglini S; Banfi G; Rivolta E; Messa P; Ponticelli C
Nephrol Dial Transplant; 2006 Jun; 21(6):1541-8. PubMed ID: 16455674
[TBL] [Abstract][Full Text] [Related]
27. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
28. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S; Kher V
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[TBL] [Abstract][Full Text] [Related]
29. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of the diffuse and focal proliferative forms of lupus nephropathy with intravenous cyclophosphamide. Intravenous cyclophosphamide in systemic lupus erythematosus].
Vigil A; Gallar P; Oliet A; Ortega O; Bajo MA
Rev Clin Esp; 1995 Aug; 195(8):524-9. PubMed ID: 7569197
[TBL] [Abstract][Full Text] [Related]
31. [Assessment on intermittent intravenous cyclophosphamide pulse therapy in diffuse proliferative lupus nephritis].
Okubo T; Ideguchi H; Ihata A; Nakamura M; Ueda A; Ohno S; Hagiwara E; Aoki A; Shirai A; Ishigatsubo Y
Ryumachi; 2000 Jun; 40(3):605-11. PubMed ID: 10920685
[TBL] [Abstract][Full Text] [Related]
32. Longterm followup of childhood lupus nephritis.
Hagelberg S; Lee Y; Bargman J; Mah G; Schneider R; Laskin C; Eddy A; Gladman D; Urowitz M; Hebert D; Silverman E
J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
34. Outcome of 85 lupus nephritis patients treated with intravenous cyclophosphamide: a single centre 10 year experience.
Chan AY; Hooi LS
Med J Malaysia; 2000 Mar; 55(1):14-20. PubMed ID: 11072485
[TBL] [Abstract][Full Text] [Related]
35. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
[TBL] [Abstract][Full Text] [Related]
36. Pulse cyclophosphamide induction treatment in Thai children with diffuse proliferative lupus nephritis.
Opastirakul S; Chartapisak W
Nephrology (Carlton); 2012 Mar; 17(3):269-73. PubMed ID: 22181066
[TBL] [Abstract][Full Text] [Related]
37. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.
Sfikakis PP; Boletis JN; Lionaki S; Vigklis V; Fragiadaki KG; Iniotaki A; Moutsopoulos HM
Arthritis Rheum; 2005 Feb; 52(2):501-13. PubMed ID: 15693003
[TBL] [Abstract][Full Text] [Related]
38. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
Danieli MG; Palmieri C; Salvi A; Refe MC; Strusi AS; Danieli G
J Clin Apher; 2002; 17(2):72-7. PubMed ID: 12210709
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
